Emergent Biosolutions Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 1.6K
- Market Cap
- $490.9M
FDA Advisers to Consider Emergent’s Narcan Spray as OTC Overdose Antidote
US health advisers to review Emergent BioSolutions' Narcan nasal spray for over-the-counter sale, aiming to increase access amid opioid crisis. FDA advisory panels to assess safety for nonprescription use, with a decision expected by March 29.
© Copyright 2025. All Rights Reserved by MedPath